CANB is the ONLY Pure CBD Oil Stock in America
FDA Enforcement Discretion— The Holy Grail for PURE CBD OIL INVESTORS ONLY
The absence of legal clarity around the CBD sector has acted to dampen investor excitement and hype around the still technically federally “illegal” CBD industry in America thus far in 2019
In the absence of FDA Regulations that would once and for all “legalize” CBD, the media and the average investor continue to view Hemp & CBD as if it were MJ & THC, fearful of a federal crackdown on an industry which was actually created by the U.S. Congress
This is Twilight Zone stuff
The agencies actually capable of any crackdown — the DOJ and the DEA — have already stepped aside because Congress legalized and removed Hemp and all of its cannabinoids from the Schedule of Controlled Substances
And Hemp Legalization happened because of Republicans, not Democrats, so the Republican-dominated FDA isn’t out to double cross their own political party
This was a 100% Mitch-engineered phenomenon, though it’s one that currently has near-unanimous support from both political parties and nearly every state in the union
The FDA isn’t a crackdown agency — they are a regulating agency — which is why CBD products of all formulations are currently found literally everywhere, even though the FDA has been stating since 2015 that they are all federally illegal
So why does there continue to be this fear around what the FDA is going to decide to do with the CBD industry?
Is it completely misguided and simply a manifestation of shell shock from the years of MJ-related setbacks due to federal government agencies putting up roadblocks every time it had appeared that MJ was about to take the next big step towards federal legality, as happened most famously with Jeff Sessions’ rescission of the Cole Memo?
I think the answer is that most of the fear surrounding the CBD industry is misguided
But NOT ALL of it
The sole element that can rationally engender fear and uncertainty in the CBD product industry concerns product formulation — which product formulation is the FDA going to federally “legalize” and allow to be sold nationally?
And on the other hand, which product formulations are going to remain federally illegal and be ineligible for national sales?
So let’s once again take a quick look at the range of CBD product formulations
Pure CBD products (CBD Isolate) = CBD only
Full Spectrum CBD products = THC + CBG/CBN/CBC + CBD
Broad Spectrum CBD products = CBG/CBN/CBC + CBD
CBD doesn’t possess any of the safety issues that come with THC — driving impairment, cognitive impairment, ER visits due to psychosis/paranoia/anxiety, effects on the developing brains of adolescents, etc.
So Pure CBD products don’t possess any of the potential safety issues that come with THC-containing Full Spectrum CBD products
The FDA views Pure CBD products as being generally safe for public consumption — Dr. Gottlieb has admitted that much at low doses and low concentrations with proper labeling and no health claims, if they are adhering to typical regulations that ensure safety such as GMPs and lab testing for impurities and contaminants — not having the scientific data to declare Pure CBD “GRAS” at this current point in time is a completely different issue — taking CBD in very high daily doses like Epidiolex (500-1500 mg) is not safe and is associated with side effects, but taking it in the more typical 10-50 mg daily dose is a completely different matter — the FDA may have failed to make the distinction between high dose and low dose, but dose is the driver of safety and side effects when we are talking about CBD, or any other molecule for that matter, and the FDA is extremely well-aware of this fact — for PR reasons, mainly the need to publicly defend the prescription pharmaceutical industry before they give the green light in 2020, along with the vaping crisis, where they let an industry go unregulated for many years and then got badly burned because of it, the FDA would never come out and say that a federally illegal product like CBD selling in a completely unregulated industry with zero manufacturing standards and no required lab testing like CBD, is safe
Let me repeat that because of its importance
The FDA views Pure CBD products as being generally safe for public consumption at low doses and low concentrations with proper labeling and no health claims, if they are adhering to typical regulations that ensure safety such as GMPs and lab testing for impurities and contaminants
However, the FDA views THC-containing Full Spectrum CBD products as being unsafe for public consumption
In terms of THC-Free Broad Spectrum products — CBG/CBN/CBC + CBD — all we have right now is a big question mark
The safety research on the other cannabinoids present in Hemp, like CBG/CBN/CBC, is practically non-existent
So nobody knows with any scientific certainty whether or not it’s safe to allow these cannabinoids in CBD products
Moreover, the pharmaceutical industry’s interest in researching CBG/CBN/CBC is growing rapidly — they do want to explore the possibility of creating prescription pharmaceuticals out of these cannabinoids — and the FDA wants to make their exception of allowing a cannabinoid, CBD, to be sold as both a pharmaceutical drug and an OTC product a one-time exception
So the FDA has 2 reasons to keep Broad Spectrum products off the market — no safety data and preserving incentives for pharmaceutical drug development
In summary, all signs point to the FDA only giving the green light to Pure CBD products
CBD products containing THC are at risk of the FDA condemning them to be sold only intrastate, just like THC-containing MJ products — though the former products are sold in all types of stores, whereas MJ products are strictly limited to dispensaries, so there will still remain a huge difference in the investability and market size of THC-containing Hemp-derived CBD products (better and larger) in comparison to THC-containing MJ products
CBD products containing CBG/CBN/CBC are also at risk of the FDA condemning them to be sold only intrastate as well
Now I’m not saying this will always be the case for Full Spectrum and Broad Spectrum CBD products
Future Congressional legislation explicitly legalizing all Hemp-derived products, including those containing THC and CBG/CBN/CBC can render the FDA’s viewpoint and thought process virtually irrelevant
But right now, as we all await the FDA’s interim regulatory framework and/or enforcement discretion strategy for the CBD industry, the only thing that matters is which specific formulation the FDA will render safe for public consumption, federal “legalization” and national sales
All of CANB’s CBD Oil products are made from Pure CBD
CANB remains the only Pure CBD Oil stock in America
Therefore, CANB is the only stock in America producing and selling a full lineup of CBD Oil products that can attain FDA approval for national sales
Sleek
